Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
218.42
-4.03 (-1.81%)
At close: Oct 9, 2026, 4:00 PM EDT
218.00
-0.42 (-0.19%)
After-hours: Oct 9, 2026, 7:53 PM EDT
Jazz Pharmaceuticals Market Cap
Jazz Pharmaceuticals has a market cap or net worth of $14.18 billion as of October 9, 2026. It is the 1,601st most valuable company in the world and the 590th biggest in the United States. Its market cap has increased by 69.65% in one year.
Market Cap
14.18B
Enterprise Value
16.39B
1-Year Change
69.65%
Global Rank
Country Rank
#590 United States
Category
ChartMarket Cap Chart
Since June 1, 2007, Jazz Pharmaceuticals's market cap has increased from $435.30M to $14.18B, an increase of 3,157.21%. That is a compound annual growth rate of 19.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 14.18B | 37.26% |
| Dec 31, 2025 | 10.33B | 38.75% |
| Dec 31, 2024 | 7.45B | -3.86% |
| Dec 29, 2023 | 7.74B | -22.80% |
| Dec 30, 2022 | 10.03B | 28.09% |
| Dec 31, 2021 | 7.83B | -14.84% |
| Dec 31, 2020 | 9.20B | 8.89% |
| Dec 31, 2019 | 8.45B | 12.94% |
| Dec 31, 2018 | 7.48B | -7.37% |
| Dec 29, 2017 | 8.07B | 23.62% |
| Dec 30, 2016 | 6.53B | -24.46% |
| Dec 31, 2015 | 8.64B | -12.72% |
| Dec 31, 2014 | 9.90B | 35.42% |
| Dec 31, 2013 | 7.31B | 137.27% |
| Dec 31, 2012 | 3.08B | 89.28% |
| Dec 30, 2011 | 1.63B | 112.63% |
| Dec 31, 2010 | 765.90M | 213.64% |
| Dec 31, 2009 | 244.20M | 340.00% |
| Dec 31, 2008 | 55.50M | -84.62% |
| Dec 31, 2007 | 360.90M | -17.09% |
| Jun 1, 2007 | 435.30M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascendis Pharma | 15.05B |
| Exelixis | 14.83B |
| Summit Therapeutics | 14.07B |
| Corcept Therapeutics | 13.10B |
| BridgeBio Pharma | 12.78B |
| Halozyme Therapeutics | 12.53B |
| Bio-Techne | 11.36B |
| ImmunityBio | 11.14B |